A joint study between Yale University, King’s College Hospital in London and Doctors Without Borders found a single shot could be made for just 89 cents.
anybody who believes pharma costs are justified by materials is… well, let’s just call them uninformed. It’s not justified by R&D costs or production issues. It’s justified by the stock market, by the CEO having a race with other pharma CEOs for the biggest bonus, and by no other thing.
Normally you can think of these prices as the reward to taking a risk. The chance of developing a drug and bringing it to market is usually small, and the reward should accordingly be high. However, in the particular case of Ozempic, the company attempted to develop a diabetes drug, and accidentally found that the drug works against obesity. That means that the reward in this case outweighs the risk by an obscene amount.
obviously
anybody who believes pharma costs are justified by materials is… well, let’s just call them uninformed. It’s not justified by R&D costs or production issues. It’s justified by the stock market, by the CEO having a race with other pharma CEOs for the biggest bonus, and by no other thing.
Normally you can think of these prices as the reward to taking a risk. The chance of developing a drug and bringing it to market is usually small, and the reward should accordingly be high. However, in the particular case of Ozempic, the company attempted to develop a diabetes drug, and accidentally found that the drug works against obesity. That means that the reward in this case outweighs the risk by an obscene amount.